Front Pharmacol. 2022 Apr 14;13:884470. doi: 10.3389/fphar.2022.884470. eCollection 2022. PMID: 35496276
https://pubmed.ncbi.nlm.nih.gov/35496276/
The work was funded by The Instituto de Salud Carlos III (to AA, PI21/00727 and RD21/0006/0005); European Regional
Development Fund; European Union’s Horizon 2020 Research and Innovation Programme (to AA, grant agreement 686009);
and Junta de Castilla y León (to AA and JB, CSI151P20 and CLU201703 P.O.FEDER CyL1420), and the Agencia Estatal de Investigación (t o JB, PID 2019-105699RB-I00, MCIN/AEI/ 10.13039/501100011033 and European Union NextGenerationEU/PRTR). RL, JA and SG-G are funded byJunta de Castilla y León (to RL and JA, CSI151P20; to SG-G, EDU/601/2020).